NABEL ELIZABETH G has filed 21 insider transactions across 3 companies since April 2023.
Most recent transaction: a grant/award of 130000 shares of Lyell Immunopharma, Inc. ($LYEL) on May 15, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Lyell Immunopharma, Inc. | $LYEL | NABEL ELIZABETH G | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 295,228,868 | 9999.99% | 0.04% |
| April 30, 2025 | Moderna, Inc. | $MRNA | NABEL ELIZABETH G | Director | M | Restricted Stock Units | 979 | $0.00 | 0.0000 | 384,000,000 | 100.00% | 0.00% |
| April 30, 2025 | Moderna, Inc. | $MRNA | NABEL ELIZABETH G | Director | A | Restricted Stock Units | 16233 | $0.00 | 16,233.0000 | 384,000,000 | 9999.99% | 0.00% |
| April 30, 2025 | Moderna, Inc. | $MRNA | NABEL ELIZABETH G | Director | M | Common Stock | 979 | $0.00 | 3,084.0000 | 384,000,000 | 46.51% | 0.00% |
| April 29, 2025 | Medtronic plc | $MDT | NABEL ELIZABETH G | Director | F | Ordinary Shares | 216 | $84.60 | 17,615.0000 | 1,289,900,000 | 1.21% | 0.00% |
| April 28, 2025 | Medtronic plc | $MDT | NABEL ELIZABETH G | Director | A | Ordinary Shares | 2083 | $84.04 | 17,831.0000 | 1,289,900,000 | 13.23% | 0.00% |
| June 14, 2024 | Lyell Immunopharma, Inc. | $LYEL | NABEL ELIZABETH G | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2024 | Moderna, Inc. | $MRNA | NABEL ELIZABETH G | Director | M | Restricted Stock Units | 732 | $0.00 | 0.0000 | 382,000,000 | 100.00% | 0.00% |
| May 6, 2024 | Moderna, Inc. | $MRNA | NABEL ELIZABETH G | Director | A | Restricted Stock Units | 979 | $0.00 | 979.0000 | 382,000,000 | 9999.99% | 0.00% |
| May 3, 2024 | Moderna, Inc. | $MRNA | NABEL ELIZABETH G | Director | M | Common Stock | 732 | $0.00 | 2,105.0000 | 382,000,000 | 53.31% | 0.00% |
| May 6, 2024 | Moderna, Inc. | $MRNA | NABEL ELIZABETH G | Director | A | Stock Option (Right to Buy) | 5668 | $0.00 | 5,668.0000 | 382,000,000 | 9999.99% | 0.00% |
| May 1, 2024 | Medtronic plc | $MDT | NABEL ELIZABETH G | Director | F | Ordinary Shares | 192 | $80.89 | 15,674.0000 | 1,330,200,000 | 1.21% | 0.00% |
| April 29, 2024 | Medtronic plc | $MDT | NABEL ELIZABETH G | Director | A | Ordinary Shares | 2165 | $80.86 | 15,866.0000 | 1,330,200,000 | 15.80% | 0.00% |
| Sept. 8, 2023 | Lyell Immunopharma, Inc. | $LYEL | NABEL ELIZABETH G | Director | A | Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Lyell Immunopharma, Inc. | $LYEL | NABEL ELIZABETH G | Director | A | Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2023 | Moderna, Inc. | $MRNA | NABEL ELIZABETH G | Director | A | Restricted Stock Units | 732 | $0.00 | 732.0000 | 416,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | Moderna, Inc. | $MRNA | NABEL ELIZABETH G | Director | A | Stock Option (Right to Buy) | 4601 | $0.00 | 4,601.0000 | 416,000,000 | 9999.99% | 0.00% |
| May 1, 2023 | Medtronic plc | $MDT | NABEL ELIZABETH G | Director | A | Ordinary Shares | 1930 | $90.68 | 13,804.0000 | 1,332,800,000 | 16.25% | 0.00% |
| May 2, 2023 | Medtronic plc | $MDT | NABEL ELIZABETH G | Director | F | Ordinary Shares | 169 | $90.23 | 13,635.0000 | 1,332,800,000 | 1.22% | 0.00% |
| April 28, 2023 | Moderna, Inc. | $MRNA | NABEL ELIZABETH G | Director | M | Restricted Stock Units | 670 | $0.00 | 0.0000 | 416,000,000 | 100.00% | 0.00% |
| April 28, 2023 | Moderna, Inc. | $MRNA | NABEL ELIZABETH G | Director | M | Common Stock | 670 | $0.00 | 1,373.0000 | 416,000,000 | 95.31% | 0.00% |